This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Cannabis food and beverage companies already have a comprehensive body of regulatory guidelines to help set themselves up for long-term success in this industry—but often with some tailored guidance specific to the unique properties of working with cannabis.
The market for cannabidiol (CBD) products is booming but new research by the Grocery Manufacturers Association (GMA) shows that consumers are confused about what CBD is, what it does and whether CBD products are safe.
The Professional Manufacturing Confectioners Association will host a symposium this fall covering all aspects of developing and producing cannabis-infused candy and snacks.
The FDA recently held a hearing designed to include information and views related to the safety of cannabis edibles and beverages—with a strong emphasis on cannabidiol (CBD) ingredients—as well as to solicit input relevant to the agency's regulatory strategy for existing products.
The US Food and Drug Administration issued on July 23 a warning letter to Curaleaf Inc. for selling products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease and opioid withdrawal, among other conditions or diseases.
An upcoming webinar will cover the U.S. Food and Drug Administration’s role in oversight of hemp-derived cannabis products and food safety concerns associated with producing them.
Patients with cancer or severe pain, for example, have been blocked from these benefits since the mid-20th century when federal regulations were enacted that prohibited the use, sales and distribution of marijuana due to its psychoactive properties
The market for legal cannabis edibles has grown increasingly sophisticated—and that includes the packaging options used for retail and medicinal products.
While more U.S. states continually pass recreational and medical cannabis legislation, opening the door to use of cannabis for personal and health-related reasons, from a national perspective, regulatory authorities lack a centralized, cohesive structure.
Create Account
